Randomized Evaluation of Aggressive or Moderate Lipid Lowering Therapy With Pitavastatin in Coronary Artery Disease (REAL-CAD)

NCT01042730 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

13054

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DRUG: Pitavastatin 1 mg daily or 4 mg daily

Sponsor

Juntendo University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]